Effect of cell-penetrating peptides on the nasal absorption of insulin

被引:98
|
作者
Khafagy, El-Sayed [1 ]
Morishita, Mariko [1 ]
Isowa, Koichi [2 ]
Imai, Jun [2 ]
Takayama, Kozo [1 ]
机构
[1] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan
[2] Ctr Japan Biol Chem Co Ltd, Gifu 5030628, Japan
基金
日本科学技术振兴机构;
关键词
Cell-penetrating peptide (CPP); Penetratin; Octaarginine; Insulin; Nasal absorption; DRUG-DELIVERY; PROTEIN TRANSDUCTION; TAT PROTEIN; IN-VITRO; MECHANISMS; MEMBRANE; DNA; INTERNALIZATION; EFFICACY; HIV-1;
D O I
10.1016/j.jconrel.2008.09.076
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The goal of this Study was to evaluate whether cell-penetrating peptides (CPPs) affect the nasal absorption of insulin. L- or D-forms of penetratin, or the L- or D-forms of octaarginine (L- or D-R8), was used as first time for nasal insulin delivery. Furthermore, the concentration of lactate dehydrogenase (LDH) in nasal lavage fluid was determined and a histopathological study of nasal respiratory epithelium was conducted. CPPs dramatically increased nasal insulin absorption, and it was more pronounced for L- and D-penetratin than L- or D-R8. L-penetratin was the most effective promoter of insulin absorption compared with others CPPs. A dose-dependent relationship of L-penetratin and insulin bioavailability was statically significant. The pharmacological availability and bioavailability of nasally administered insulin Was LIP to 76.7% and 50.7% relative to the Subcutaneous route, respectively. In contrast, increasing the D-penetratin concentration decreased the efficiency of nasal insulin absorption. There was no significant difference ill the release of LDH in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-penetratin was present. In conclusion. these data demonstrate that L-penetratin markedly increased the permeability of insulin across the nasal membrane without Causing detectable damage to the integrity of cells in the nasal respiratory mucosa. (K) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [1] Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins
    Khafagy, El-Sayed
    Morishita, Mariko
    Kamei, Noriyasu
    Eda, Yoshimi
    Ikeno, Yohei
    Takayama, Kozo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 381 (01) : 49 - 55
  • [2] Usefulness of cell-penetrating peptides to improve intestinal insulin absorption
    Kamei, Noriyasu
    Morishita, Mariko
    Eda, Yoshimi
    Ida, Nobuo
    Nishio, Reiji
    Takayama, Kozo
    JOURNAL OF CONTROLLED RELEASE, 2008, 132 (01) : 21 - 25
  • [3] Cell-penetrating peptides
    Lindgren, M
    Hallbrink, M
    Prochiantz, A
    Langel, U
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) : 99 - 103
  • [4] Identification and Characterization of a New Family of Cell-penetrating Peptides CYCLIC CELL-PENETRATING PEPTIDES
    Cascales, Laura
    Henriques, Sonia T.
    Kerr, Markus C.
    Huang, Yen-Hua
    Sweet, Matthew J.
    Daly, Norelle L.
    Craik, David J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (42) : 36932 - 36943
  • [5] One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats
    Khafagy, El-Sayed
    Kamei, Noriyasu
    Nielsen, Ebbe Juel Bech
    Nishio, Reiji
    Takeda-Morishita, Mariko
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 736 - 743
  • [6] Noninvasive insulin delivery: the great potential of cell-penetrating peptides
    Kamei, Noriyasu
    Nielsen, Ebbe Juel Bech
    Khafagy, El-Sayed
    Takeda-Morishita, Mariko
    THERAPEUTIC DELIVERY, 2013, 4 (03) : 315 - 326
  • [7] Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination
    Lobaina, Yadira
    Urquiza, Dioslaida
    Garay, Hilda
    Perera, Yasser
    Yang, Ke
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (04) : 2873 - 2882
  • [8] Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination
    Yadira Lobaina
    Dioslaida Urquiza
    Hilda Garay
    Yasser Perera
    Ke Yang
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 2873 - 2882
  • [9] The case for cell-penetrating peptides
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 615 - 616
  • [10] The Pharmacokinetics of Cell-Penetrating Peptides
    Sarko, Dikran
    Beijer, Barbro
    Boy, Regine Garcia
    Nothelfer, Eva-Maria
    Leotta, Karin
    Eisenhut, Michael
    Altmann, Annette
    Haberkorn, Uwe
    Mier, Walter
    MOLECULAR PHARMACEUTICS, 2010, 7 (06) : 2224 - 2231